Instrument Inactif

Autres langues Cambrex Corporation

Actions

CBM

Produits pharmaceutiques

Autres langues

23/03	Cambrex Advances Us and European Expansions
22/10/25	Cambrex Corporation announced that it has received $120 million in funding
22/10/25	Cambrex Unveils $120 Million Investment to Expand API Manufacturing and Strengthen U.S. Drug Supply Resilience
05/12/24	Cambrex Announces Strategic Agreement with Eli Lilly and Company to Support Biotech Collaborator Manufacturing
02/11/23	Noramco, Inc. acquired Drug Product Business Unit of Cambrex Corporation.
02/11/23	Noramco, Inc. acquired Halo Pharma, Inc. from Cambrex Corporation.
31/05/23	Cambrex Announces Grand Opening of New First Stability Storage Commercial Agreement
04/04/23	Cambrex Opens New Stability Storage Facility in Belgium
18/01/23	Cambrex Corporation completed the acquisition of Snapdragon Chemistry, Inc.
21/11/22	Cambrex Corporation entered into a definitive agreement to acquire Snapdragon Chemistry, Inc.
27/10/22	Cambrex to Invest $16.5 Million in New R&D Facility in Minneapolis, Minnesota and Expansion in Charles City, Iowa
04/10/22	Cambrex Corporation Announces Stability Storage Expansions in Ireland and Belgium
01/09/22	Cambrex Completes First Phase of $30 Million Capacity Expansion Project in High Point, North Carolina
01/06/22	Cambrex Corporation acquired Q1 Scientific Limited.
12/04/22	Cambrex Completes Large-Scale US API Expansion
01/03/22	Cambrex Corporation Expands Biopharmaceutical Services Business
07/10/21	Cambrex to Invest $30 Million to Expand Manufacturing Center of Excellence At High Point, NC Facility
23/06/21	Omega Therapeutics Expands Board of Directors with Appointment of Luke Beshar
26/05/21	Cambrex Introduces New Kilogram-Scale Gmp Manufacturing Capabilities At Tallinn, Estonia Facility
05/05/21	Cambrex Expands Analytical Services Capabilities at Longmont, Colorado, Facility
17/11/20	Cambrex to Invest $50 Million to Expand Multipurpose Large-Scale Manufacturing Capabilities in the U.S
12/10/20	Cambrex Completes Major Expansion of Solid Form Screening Facility in Edinburgh
01/07/20	Cambrex Increases Flexible Manufacturing Capacity at Karlskoga, Sweden Facility
18/06/20	Cambrex Appoints Thomas Loewald as Member of the Board of Directors Effective September 7, 2020
18/06/20	Cambrex Appoints Thomas Loewald as Chief Executive Officer Effective September 7, 2020